Dataset : PharmaTrac MAT MAY PharmaTrac Overview MAY 18
|
|
|
- Cory Carson
- 5 years ago
- Views:
Transcription
1 PharmaTrac Overview MAY 18
2 INDUSTRY DYNAMICS: For the first time in last 12 months the market has shown a more than 10% growth on monthly basis all chronic segment growing above 10% Indian Pharma Market Trends APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR GR % GR % GR %
3 QOQ DYNAMICS: The QRT has posted the highest growth as compared to last three quarters Q 1 15 Q 2 15 Q 3 15 Q 4 15 Q 1 16 Q 2 16 Q 3 16 Q 4 16 Q 1 17 Q 2 17 Q 3 17 Q 4 17 Q 1 18 INCRE VALUE GR
4 Only Lupin is showing a double digit growth on MAT basis amongst top corporates. Abbott, Lupin, Alkem, torrent and Macleods are showing double digit growth on running qrt basis SUN* ABBOTT* CIPLA ZYDUS* LUPIN MANKIND ALKEM* TORRENT GSK MACLEODS AV BV GR RUN-QTR GR MAY
5 ACUTE/CHRONIC SPLIT: Chronic segment are driving growth GR IPM SUN* ABBOTT* CIPLA ZYDUS* LUPIN MANKIND ALKEM* TORRENT GSK MACLEODS IPM SUN* ABBOT T* CIPLA ZYDUS* LUPIN MANKIND ALKEM* TORRENT GSK MACLEODS ACUTE CHRONIC SUB CHRONIC
6 RANK SPLIT: Top 10 Contribute 43.82% and are growing above the IPM as a group MAY-17 MAY TOP TOP May-17 May-18 MAT VAL MS GR CORPORATE MAT VAL MS GR IPM TOP
7 INDIAN/MNC SPLIT: Indian Companies dominate & are growing above the Market GR VAL : 5.9 IPM GR VAL : 6.2 GR VAL : 7.1 MANKIN D, 4385 NOVARTI S*, 1385 LUPIN, SANOFI INDIA, 2737 ZYDUS*, PFIZER*, 2872 CIPLA, 5538 GSK, 3630 SUN*, INDIAN MNC ABBOTT*,
8 ZONAL SPLIT: South dominates North picks up a fast pace.. MAT VAL MAY 18 ZONE MAT VAL MS MS (G / L) GR INCRE VAL IPM % 0.00% SOUTH ZONE % -0.25% NORTH ZONE % 0.55% WEST ZONE % -0.01% EAST ZONE % -0.10% ALL INDIA ONLY % -0.19% MAY-17 MAY-18 ZONE 19.9% 20.1% 26.6% 19.8% 26.3% 20.1% SOUTH ZONE 22.2% 23.5% 25.4% 23.5% 25.8% 26.8% NORTH ZONE WEST ZONE EAST ZONE 22.1% 26.0%
9 Top 3 Markets constitutes almost 38% of IPM.Anti-Diabetics add Maximum. MAT VAL MAY 18 MS SUPERGROUP SV BV GR INCRE VAL BV % TO SV SV BV IPM ANTI-INFECTIVES CARDIAC GASTRO INTESTINAL ANTI DIABETIC VITAMINS / MINERALS / NUTRIENTS RESPIRATORY PAIN / ANALGESICS DERMA NEURO / CNS GYNAECOLOGICAL ANTI-NEOPLASTICS OPHTHAL / OTOLOGICALS VACCINES HORMONES BLOOD RELATED UROLOGY OTHERS SEX STIMULANTS / REJUVENATORS STOMATOLOGICALS ANTI MALARIALS
10 Mixtard is the leading brand..6 out of top 20 Anti-diabetic and 4 out of Top 5 Brands are Anti-Diabetic. RANK May-18 May-18 G/L BRAND SUBGROUP CORPORATE SV AV BV GR INCRE 0 0 IPM MIXTARD HUMAN PREMIX INSULIN ABBOTT* SPASMO PROXYVON PLUS DICYCLOMINE + PARACETAMOL + TRAMADOL WOCKHARDT GLYCOMET GP GLIMEPIRIDE + METFORMIN USV GALVUS MET VILDAGLIPTIN + METFORMIN NOVARTIS* JANUMET SITAGLIPTIN + METFORMIN MSD* LANTUS GLARGINE SANOFI INDIA AUGMENTIN AMOXYCILLIN + CLAVULANIC ACID GSK LIV 52 HEPATIC PROTECTORS INCLUDING AYURVEDIC HIMALAYA CLAVAM AMOXYCILLIN + CLAVULANIC ACID ALKEM* MONOCEF CEFTRIAXONE ARISTO PHENSEDYL COUGH LINCTUS CHLORPHENIRAMINE + CODEINE ABBOTT* SYNFLORIX PNEUMONIA GSK THYRONORM LEVO-THYROXINE (SYNTHETIC) ABBOTT* DUPHASTON DYDROGESTERONE ABBOTT* NOVOMIX BIPHASIC ASPART ABBOTT* FORACORT FORMOTERAL + BUDESONIDE CIPLA PAN PANTOPRAZOLE ALKEM* VOVERAN DICLOFENAC NOVARTIS* ULTRACET PARACETAMOL + TRAMADOL JANSSEN PAN D DOMPERIDONE + PANTOPRAZOLE ALKEM*
11 6130 Brands launched in last 24 months May-18 BRAND SUBGROUP COMPANY LD MAT VAL INCRE VAL NI BRANDS(LAST 24 MONTHS) HEXAXIM COMBINATIONS WITH TETANUS COMPONENT SANOFI INDIA Oct GIBTULIO EMPAGLIFLOZIN LUPIN Sep EASY SIX ALL OTHER VACCINES PANACEA Apr VELPANAT SOFOSBUVIR + VELPATASVIR NATCO May OXRA DAPAGLIFLOZIN SUN* Aug OTRIVIN OXY OXYMETAZOLINE GSK Jun VYMADA SACUBITRIL + VALSARTAN NOVARTIS* Feb FUNGICROS AMOROLFINE SUN* Feb AMBRODIL S PLUS LEVOSALBUTAMOL + AMBROXOL ARISTO Aug SHELCAL XT CALCIUM CARBONATE + VIT D3 (CHOLECALCIFEROL) TORRENT Jun LULICAN LULICONAZOLE GLENMARK Jul CEASTRA ITRACONAZOLE EMCURE* Sep PRIORIX TETRA COMBINATIONS WITH MEASLES AND / OR MUMPS (E.G. MMR) GSK Jul LULIBET LULICONAZOLE INTAS Jul BEVATAS BEVACIZUMAB INTAS Oct VELASOF SOFOSBUVIR + VELPATASVIR HETERO Jun IWIN ITRACONAZOLE SUN* Apr INSTGRA DOLUTEGRAVIR EMCURE* Mar PALBACE PALBOCICLIB PFIZER* Dec ZYLPAN PANTOPRAZOLE HETERO Mar
12 657 Brands cross 10 Crs launched.67 NIs in Itraconazole & 59 NIs in Teneligliptin combination segment May-18 BRAND SUBGROUP COMPANY LD MAT VAL INCRE VAL NI BRANDS(LAST 24 MONTHS) DYNAGLIPT M TENELIGLIPTIN + METFORMIN MANKIND Oct CIZUMAB BEVACIZUMAB HETERO May CIDMUS SACUBITRIL + VALSARTAN LUPIN May ROSUVA GOLD ASPIRIN + ROSUVASTATIN + CLOPIDOGREL SUN* Jun HETEXONE CEFTRIAXONE HETERO Mar TENGLYN M TENELIGLIPTIN + METFORMIN ZYDUS* Jun PRUVICT PRUCALOPRIDE TORRENT Apr RANTAC DOM DOMPERIDONE + RANITIDINE JB CHEMICALS Jan OSTERI TERIPARATIDE EMCURE* Jul ACOGUT ACOTIAMIDE LUPIN Aug LULIMAC LULICONAZOLE MACLEODS Oct DUBINOR PREGABALIN + METHYLCOBALAMIN + NORTRYPTILINE GLENMARK Aug OVIGYN D3 DEHYDROEPIANDROSTERONE COMBINATIONS ALEMBIC Jul EMLUZ LULICONAZOLE EMCURE* Nov PEMPRO PEMETREXED ZYDUS* Jul EGLUCENT MIX REGULAR HUMAN INSULIN LUPIN Jan AZMARDA SACUBITRIL + VALSARTAN CIPLA Mar FIBROEASE MIFEPRISTONE AKUMENTIS Jun OLYMPRIX M TENELIGLIPTIN + METFORMIN ALKEM* Jul POMALID POMALIDOMIDE NATCO Jun
13
RESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013
Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013 Sl. No. F.No. Name of the Company/ Formulation Date of receipt of application
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
Indian pharma market Monthly performance tracker
Sector Update 15 January Healthcare 2015 Sector Update Healthcare Indian pharma market Monthly performance tracker Sustained growth recovery, expect momentum to pick up Performance of top companies: December
Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33
Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above
Indian Pharma Market closing the year on a high note
Performance of top companies: March 2015 Company YoY Growth (%)_ 4Q FY15 Mar- 15 IPM 17.3 20.9 Abbott India 19.9 23.9 Sun Pharma 12.6 15.0 Cipla 20.5 24.9 Zydus Cadila 6.7 9.1 Mankind 20.2 28.7 Alkem 16.0
New Delhi, the 18 th December, 2017 ORDER
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New
Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age)
Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age) Glossary: IPV= Injectable Polio vaccine OPV= Oral polio vaccine (these are oral drops, which is also given in "Pulse Polio
US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station
Click here for the corrections made < Reference > December 3, 212 Tokyo Electric Power Company Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station * As of
ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
Sleep Market Panel. Results for June 2015
Sleep Market Panel Results for June 2015 Notes: o This is a monthly trending report of panel member data along with additional analysis by: Sleep labs affiliated with Hospitals vs. Independent Labs o Hospital
Kansas EMS Naloxone (Narcan) Administration
Kansas EMS Naloxone (Narcan) Administration Executive Summary Kansas Board of Emergency Medical Services August 217 The following pages denote an ongoing trending of naloxone administration by Kansas Emergency
Rezicure Pharmaceuticals
+91-8071806292 Rezicure Pharmaceuticals https://www.indiamart.com/rezicurepharmaceuticals/ We are a well known trader and supplier of capsules, injections, syrups, ayurvedic medicines, dry syrups and many
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
LETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
RTT Exception Report
Appendix 3 RTT Exception Report 1. Purpose To provide a summary of factors impacting on 18 week RTT performance and a revised forecast of red rated performance for Quarter 2 2015/16 for the admitted pathway.
What s New
What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related
McLean ebasis plus TM
McLean ebasis plus TM Sample Hospital (0000) Report For Qtr HBIPS Core Measures McLean Hospital 115 Mill Street Belmont, MA 02478 1 2012 Department of Mental Health Services Evaluation Tel: 617-855-3797
Data Visualization - Basics
Data Visualization - Basics The Visualization Process ACQUIRE PARSE FILTER MINE REPRESENT REFINE INTERACT Sales Data (US $ in thousands) Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Domestic
Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100
Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing
FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS
AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS FIRM CAPACITY - First Monday of July 01.06.2019* 01.07.2019 07:00 01.10.2019 04:00 01.10.2020 04:00 2019/2020 01.10.2020 04:00 01.10.2021
Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 3: January 14 to January 2, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?
FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)? A: We send letters and/or profiles to PCPs with female members
PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars
PBS Growth The changing composition of the PBS PBS Top 10 drugs in transition Shifting sands for industry as generic volume soars The under co-payment market PBS Update 2014-15 Growth in PBS spending was
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY
TODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 4: January 21 to January 27, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.
Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable
Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093
DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal
Portfolio Strategy Group
PSG's Weekly Chart Perspective Portfolio Strategy Group Report Date: Monday, September 27, 21 Daily Close UST 1 Year CMT 5 Year History 5. 4.5 4. 3.5 3. 2.5 2. US Recession Sep-5 Dec-5 Mar-6 Jun-6 Sep-6
Seasonality of influenza activity in Hong Kong and its association with meteorological variations
Seasonality of influenza activity in Hong Kong and its association with meteorological variations Prof. Paul Chan Department of Microbiology The Chinese University of Hong Kong Mr. HY Mok Senior Scientific
LETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
Analysis of Meter Reading Validation Tolerances proposed by Project Nexus
Analysis of Meter Reading Validation Tolerances proposed by Project Nexus January 2014 Description of analysis Aim of analysis: To assess the impact of the meter read validation tolerances that have been
Portfolio Strategy Group
PSG's Weekly Chart Perspective Portfolio Strategy Group Report Date: Monday, November 15, 21 Daily Close UST 1 Year CMT 5 Year History 5. 4.5 4. 3.5 3. 2.5 2. US Recession Nov-5 Feb-6 May-6 Aug-6 Nov-6
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England
The Infection Control Doctor and Clostridium difficile infection Dr David R Jenkins University Hospitals of Leicester NHS Trust, England 250 200 150 100 50 0 Monthly cases of Clostridium difficile (UHL
Short Range Outlook for Steel Demand Autumn OECD Steel Committee, Paris, 10 December Short Range Outlook overview
Short Range Outlook for Steel Demand Autumn 29 OECD Steel Committee, Paris, 1 December 29 Content Short Range Outlook overview Background of the Forecast Regional overviews Conclusion 2 1 Short Range Outlook
ONLINE SUPPLEMENTARY APPENDIX. Webtable 1: Survey facilities random sampling
ONLINE SUPPLEMENTARY APPENDIX Webtable 1: Survey facilities random sampling Delhi, also known as the National Capital Territory (NCT) of Delhi, is divided into total 11 districts namely New Delhi, North
Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written
Marketing on a Budget: Monthly quit & win challenges to drive quitline utilization. Presenters: John Atkinson & Elizabeth Harvey
Marketing on a Budget: Monthly quit & win challenges to drive quitline utilization Presenters: John Atkinson & Elizabeth Harvey WHAT IS THE FIRST WEEK CHALLENGE? Monthly campaign Register online or by
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
Medicinal products of Kusum Pharm Ltd. registered in Ukraine - 1 -
- 1-1. Abrol tablets 30, No. 20 (10 2) in 1 tablet contains ambroxol hydrochloride 30 UA/9928/01/01 2. Abrol syrup, 15 /5 ml, 100 ml in a bottle 5 ml of syrup contain ambroxol hydrochloride15 Medicines
18 Week 92% Open Pathway Recovery Plan and Backlog Clearance
18 Week 92% Open Pathway Recovery Plan and Backlog Clearance Page 1 of 6 17.05.2012 1.0 Background 18-Week 92% Open Pathway RECOVERY PLAN The Trust has achieved compliance against the admitted and non-admitted
This document was created on 07 January 2005 and has been printed from
1 Spontaneous Adverse Event Reporting Information Introduction This document provides information regarding spontaneous adverse event reports received concerning patients taking rosuvastatin, which relates
Current and future market dynamics overview
OVERVIEW Catalyst Summary EXECUTIVE SUMMARY Strategic scoping and focus Datamonitor key findings Related reports MARKET DEFINITION Published diabetes reports Market definition for antidiabetic drugs Forecast
Expanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
6 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu
PRODUCT MANUFACTURING LIST Tablet SECTIONS :- S.No. Composition Claim Pack Size Packing Type Remarks 1 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu 2 Each Film coated Tablet Contains
PRODUCT LIST GENERAL - TABLETS
SR. NO. PRODUCT LIST GENERAL - TABLETS 1 Ciprofloxacin Tablets IP 500 mg 2 Ciprofloxacin And Tinidazole Tablets 3 Cefpodoxime Proxetil Tablets IP 4 Cefixime Dispersible Tablets 200 mg 5 Cefixime Dispersible
Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
Jay H. Hoofnagle, M.D. Director, Liver Disease Research Branch Division of Digestive Diseases and Nutrition National Institute of Diabetes and
Jay H. Hoofnagle, M.D. Director, Liver Disease Research Branch Division of Digestive Diseases and Nutrition National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health,
Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free
Investor Day EEMA Region Lausanne, September 29, 2016 Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Agenda Overview and Key Results Vision and Strategic Pillars
Novartis Pharmaceuticals Corporation - US Postmarketing Commitments October 2016 (Ongoing)
Novartis Pharmaceuticals Corporation - US Postmarketing Commitments October 2016 () Brand Name Generic Name Application Commitment Number Approval Date Commitment Number/Description Afinitor Everolimus
Dementia Content Report January Produced By The NHS Choices Reporting Team
Dementia Content Report January 2014 Produced By The NHS Choices Reporting Team CH.NHSChoices-Reporting@nhs.net Dementia Dashboard Page 1 Overall Choices Site Visits Tag cloud showing top dental related
Dementia Content Report May Produced By The NHS Choices Reporting Team
Dementia Content Report May 2013 Produced By The NHS Choices Reporting Team CH.NHSChoices-Reporting@nhs.net 35.0M 30.0M 25.0M 20.0M 15.0M 10.0M 5.0M 0.0 15.9M Overall Choices Site Visits NHS Choices Policy
Novartis Pharmaceuticals Corporation - US Postmarketing Commitments Ongoing [October 2018]
![Novartis Pharmaceuticals Corporation - US Postmarketing Commitments Ongoing [October 2018]](/thumbs/90/103470094.jpg "Novartis Pharmaceuticals Corporation - US Postmarketing Commitments Ongoing [October 2018]")
Novartis Pharmaceuticals Corporation - US Postmarketing s [October 2018] /Description Afinitor Everolimus BHT 22334 30-Mar-2009 PMR#3031-1: To submit the clinical study report and datasets for the final
U.S. Flue-Cured Tobacco Situation & Outlook February 6, 2015
U.S. Flue-Cured Tobacco Situation & Outlook February 6, 2015 Dr. Blake Brown Hugh C. Kiger Professor Agriculture & Resource Economics College of Agriculture & Life Sciences How much are contracted pounds
NORTHERN HEALTH AND SOCIAL CARE TRUST. Waiting Times Summary Report
NORTHERN HEALTH AND SOCIAL CARE TRUST Waiting Times Summary Report April 2014 1 Waiting Times The Northern Health & Social Care Trust monitors waiting time performance against a number of Departmental
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting
Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting Eric B. Durbin, DrPH, MS, Director of Cancer Informatics Frances E. Ross, CTR,
From Analytics to Action
From Analytics to Action Overview So, what are we talking about here? How to make incremental changes to your digital content that will result in positive user actions Overview Rooted in the hard sciences
Measles: United States, January 1 through June 10, 2011
Measles: United States, January 1 through June 10, 2011 Preeta K. Kutty, MD, MPH Measles, Mumps, Rubella and Polio Team Division of Viral Diseases Centers for Disease Control and Prevention Atlanta, GA
3. Cardiovascular Disease?
Swiss recommendations 2016 Swiss Society of Endocrinology and Diabetology 1. Deficiency? Basal Premixed- Basal + GLP-1 RA (Xultophy ) or Basal Bolus 2. egfr < 30 ml/min? 3. Cardiovascular Disease? 4. Heart
https://www.indiamart.com/cureworld-pharmaceutical/
+91-8071677510 Cure World Pharmaceutical https://www.indiamart.com/cureworld-pharmaceutical/ We are one of the leading Manufacturer and Trader of an excellent quality Pharmaceutical Tablet, Pharmaceutical
Chairman, GPCB Gandhinagar, Gujarat. CSE Conference on Health and Environment March 24-25, 2006
Health Impacts of Air Pollution in Ahmedabad Presentation by K. V. Bhanujan Chairman, GPCB Gandhinagar, Gujarat CSE Conference on Health and Environment March 24-25, 2006 India Habitat Centre, New Delhi
Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes
Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Organisation Name: Ko Awatea, Counties Manukau Health Presenter: Bob Diepeveen HRT 1520 Innovations
Innovative solutions for improving vitamin D nutrition and health in Europe
Innovative solutions for improving vitamin D nutrition and health in Europe Mairead Kiely Professor of Human Nutrition University College Cork, Ireland 23/10/2017 1 Vitamin D deficiency is not a new problem
LETTERS FOR ISSUE ON
S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS
An Updated Approach to Colon Cancer Screening and Prevention
An Updated Approach to Colon Cancer Screening and Prevention Kevin Liebovich, MD Director for Quality for Gastrointestinal diseases Advocate Condell Medical Center Colon Cancer Screening and Prevention
Durham Region Influenza Bulletin: 2017/18 Influenza Season
Durham Region Influenza Bulletin: 2017/18 Influenza Season Surveillance Week 21 (May 20, 2018 to May 26, 2018) Table 1: Assessment of influenza activity in Durham Region Measure Laboratory confirmed cases
Magellan s Transport Route Lead Monitoring Program
Magellan s Transport Route Lead Monitoring Program Magellan s lead monitoring requirements Magellan s approval to export sealed shipments of lead carbonate through Fremantle is subject to the Interim Implementation
8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week )
8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 213 (covering week 33 213) Current level of activity: Low Trend: Stable compared to last week News: Update Middle East
Proceed. Award. Resident Auditor University for C.Y Award. Proceed
(PAMANTASAN NG LUNGSOD NG MAYNILA) Monitoring Report as of 01/08/2013 s Actual Activity 2012-G-01 Supply, Installation, Information Public ding 17-Jan-12 04-Feb-12 10-Feb-12 24-Feb-12 24-Feb-12 29-Feb-12
Disclosures. Learning Objectives. Improving HPV Immunization Rates in a Large Pediatric Practice: Implementing Effective Quality Improvement
Improving HPV Immunization Rates in a Large Pediatric Practice: Implementing Effective Quality Improvement Alix Casler, M.D., F.A.A.P. Medical Director of Pediatrics, Orlando Health Physician Associates
Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events. September 13, 2016
Implementation of an Interprofessional Team to Prevent Inpatient Hypoglycemic Events September 13, 2016 St Joseph s Health Fast Facts Founded 1869 by Sisters of St. Francis Patient Volumes (2014) Inpatient
Utilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013
Utilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013 Montréal, Canada MISSION To provide 100% access to
Adult Immunizations. Business Health Care Group (BHCG) April 25, Cathy Edwards. Immunization Program Advisor
Adult Immunizations Business Health Care Group (BHCG) April 25, 2012 Cathy Edwards Immunization Program Advisor Wisconsin Department of Health Services Division of Public Health 1 Adult Immunizations WHY
NHS WALES PRIMARY CARE PRESCRIBING ANALYSIS FOR TRAMADOL DATA TO SEPTEMBER 2014
NHS WALES PRIMARY CARE PRESCRIBING ANALYSIS FOR TRAMADOL DATA TO SEPTEMBER 2014 March 2015 This report has been prepared by the Welsh Analytical Prescribing Support Unit (WAPSU), part of the All Wales
REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
Stellar- Bio Labs.
+91-8048763969 Stellar- Bio Labs https://www.indiamart.com/stellar-biolabs/ As a largest integrated research based pharmaceutical company, we are engaged in formulation, supply and trade of general medicines
Assessing Change with IIS. Steve Robison Oregon Immunization Program
Assessing Change with IIS Steve Robison Oregon Immunization Program Assessing Change with IIS Steve Robison Oregon Immunization Program Overview IIS Use in Public Health Static vs Dynamic Assessment Working
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: January 03, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
Has the UK had a double epidemic?
Has the UK had a double epidemic? Dr Rodney P Jones Healthcare Analysis & Forecasting www.hcaf.biz hcaf_rod@yahoo.co.uk Introduction Outbreaks of a new type of epidemic, possibly due to immune manipulation,
Hand, Foot, and Mouth Disease Situation Update. Hand, Foot, and Mouth Disease surveillance summary
Hand, Foot, and Mouth Disease Situation Update 24 February 215 Hand, Foot, and Mouth Disease surveillance summary This surveillance summary includes information from countries where transmission of Hand,
Analysis of Greater Glasgow & Clyde IEP Data John Campbell
Analysis of Greater Glasgow & Clyde IEP Data 2-2 John Campbell Contents Overview of the programme... 3 About this report... 4 Key points... 4 Drugs injected... 5 Drugs injected at transaction by unique
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709
Campaigns Overview. Lisa Bainbridge Head of Campaigns 14 October 2017
Campaigns Overview Lisa Bainbridge Head of Campaigns 14 October 2017 Introduction What has been our impact on helping more people to secure a diagnosis of coeliac disease? What can you now expect from
Eli Lilly and Company Investment Community Meeting
Eli Lilly and Company Investment Community Meeting October 3, 2013 8:30 a.m. 12:30 p.m. Safe Harbor Provision This presentation contains forward-looking statements that are based on management's current
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
South Plains Emergency Medical Services, Inc. P.O. Box Lubbock, Texas 79453
South Plains Emergency Medical Services, Inc. P.O. Box 53597 Lubbock, Texas 79453 June 28, 2017 TO: SPEMS EMS Services SUBJECT: SPEMS PARAMEDIC PROTOCOL VARIANCE With the ongoing medication shortages,
Breast Test Wales Screening Division Public Health Wales
Breast Test Wales Screening Division Public Health Wales Programme Level Agreement with Welsh Government Quarterly Report October - December Breast Test Wales - Quarterly Report October - December Service
Date : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark
Number 1. s 29 Jul 13 N/A Environmental Permit to construct the Passenger Clearance and associated works of the Hong Kong Zhuhai and Macao Bridge Boundary Crossing Facilities EP-353/2009/G 06 Aug 13 N/A
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
Emerging Respiratory Infections NZ Amanda McNaughton Respiratory Physician CCDHB Wellington
Emerging Respiratory Infections NZ 2015 Amanda McNaughton Respiratory Physician CCDHB Wellington Respiratory Infection: overview Influenza virus Clinical picture Emerging infection New Zealand Influenza
Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus